© The Financial Times Ltd 2014 FT and 'Financial Times' are trademarks of The Financial Times Ltd.
As of Nov 22, 2014, the consensus forecast amongst 57 polled investment analysts covering GlaxoSmithKline plc advises investors to hold their position in the company. This has been the consensus forecast since the sentiment of investment analysts deteriorated on Feb 21, 2013. The previous consensus forecast advised that GlaxoSmithKline plc would outperform the market.
|Last year||3 months ago||2 months ago||4 weeks ago||Latest|
The 22 analysts offering 12 month price targets for
|Div growth (TTM)||+5.41%|
On Oct 22, 2014,
The next earnings announcement is expected on Feb 04, 2015. View Full Interim Financials
|Average growth rate||+2.88%|
The next earnings announcement from
|Average growth rate||-1.42%|
GlaxoSmithKline plc had 3rd quarter 2014 revenues of 6bn. This missed the 6bn consensus estimate of the 9 analysts following the company. This was 1.53% above the prior year's 3rd quarter results. View Full Interim Financials
|Average growth rate||-3.01%|
GlaxoSmithKline plc had revenues for the full year 2013 of 27bn. This was 0.28% above the prior year's results. View Full Annual Financials
|Average growth rate||-1.67%|